Contribution of Proline Residue for Efficient Production of MHC Class I Ligands by Proteasomes*
暂无分享,去创建一个
Shin-ichiro Niwa | H. Nakajima | N. Tanahashi | N. Shimbara | Nobuyuki Tanahashi | Y. Hidaka | Naoki Shimbara | Kiyoko Ogawa | Yuko Hidaka | Hiroto Nakajima | Naoko Yamasaki | Keiji Tanaka | Keiji Tanaka | S. Niwa | N. Yamasaki | K. Ogawa
[1] C. Slaughter,et al. Primary structures of two homologous subunits of PA28, a γ‐interferon‐inducible protein activator of the 20S proteasome , 1995, FEBS letters.
[2] P. Kloetzel,et al. The Interferon-γ-inducible 11 S Regulator (PA28) and the LMP2/LMP7 Subunits Govern the Peptide Production by the 20 S Proteasome in Vitro(*) , 1995, The Journal of Biological Chemistry.
[3] Y. Murakami,et al. ATP- and antizyme-dependent endoproteolysis of ornithine decarboxylase to oligopeptides by the 26 S proteasome. , 1994, The Journal of biological chemistry.
[4] Vladimir Brusic,et al. MHCPEP, a database of MHC-binding peptides: update 1996 , 1997, Nucleic Acids Res..
[5] H. Wada,et al. Rejection antigen peptides on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes: derivation from the normally untranslated 5' region of the c-akt proto-oncogene activated by long terminal repeat. , 1995, Cancer research.
[6] K Eichmann,et al. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. , 1995, Immunity.
[7] Wolfgang Baumeister,et al. Potential Immunocompetence of Proteolytic Fragments Produced by Proteasomes before Evolution of the Vertebrate Immune System , 1997 .
[8] C. Slaughter,et al. Identification, purification, and characterization of a protein activator (PA28) of the 20 S proteasome (macropain). , 1992, The Journal of biological chemistry.
[9] C. Hahn,et al. The requirement for proteasome activity class I major histocompatibility complex antigen presentation is dictated by the length of preprocessed antigen , 1996, The Journal of experimental medicine.
[10] J. Monaco,et al. The genetics of proteasomes and antigen processing. , 1995, Annual review of genetics.
[11] K Tanaka,et al. Structure and functions of the 20S and 26S proteasomes. , 1996, Annual review of biochemistry.
[12] Hans-Georg Rammensee,et al. A role for the proteasome regulator PA28α in antigen presentation , 1996, Nature.
[13] R. Tampé,et al. Effects of major-histocompatibility-complex-encoded subunits on the peptidase and proteolytic activities of human 20S proteasomes. Cleavage of proteins and antigenic peptides. , 1996, European journal of biochemistry.
[14] K. Rock,et al. Antigen processing and presentation by the class I major histocompatibility complex. , 1996, Annual review of immunology.
[15] Hans-Georg Rammensee,et al. Coordinated Dual Cleavages Induced by the Proteasome Regulator PA28 Lead to Dominant MHC Ligands , 1996, Cell.
[16] J. Neefjes,et al. Peptide selection by MHC-encoded TAP transporters. , 1994, Current opinion in immunology.
[17] T. Yasuda,et al. Identification of a unique antigen peptide pRL1 on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes and its relation to the Akt oncogene , 1994, The Journal of experimental medicine.
[18] A. Goldberg,et al. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules , 1994, Cell.
[19] P. Kloetzel,et al. The cleavage preference of the proteasome governs the yield of antigenic peptides , 1995, The Journal of experimental medicine.
[20] K. Ferrell,et al. Purification of an 11 S regulator of the multicatalytic protease. , 1992, The Journal of biological chemistry.
[21] S. Tonegawa,et al. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. , 1994, Immunity.
[22] T. Fujiwara,et al. Molecular properties of the proteasome activator PA28 family proteins and γ‐interferon regulation , 1997, Genes to cells : devoted to molecular & cellular mechanisms.
[23] A. Ikai,et al. Proteasomes (multi-protease complexes) as 20 S ring-shaped particles in a variety of eukaryotic cells. , 1988, The Journal of biological chemistry.
[24] P M Kloetzel,et al. A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. , 1996, Immunity.
[25] U. Koszinowski,et al. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein , 1991, Cell.
[26] P. Cresswell,et al. How selective is the transporter associated with antigen processing? , 1996, Immunity.
[27] J. Neefjes,et al. The proteasome‐specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells , 1997, European journal of immunology.
[28] P M Kloetzel,et al. Peptide antigen production by the proteasome: complexity provides efficiency. , 1996, Immunology today.
[29] P M Kloetzel,et al. Interferon gamma stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes , 1994, The Journal of experimental medicine.
[30] N. Tanahashi,et al. Proteasomes and antigen processing. , 1997, Advances in immunology.
[31] S. Matsufuji,et al. Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination , 1992, Nature.
[32] K. Rajewsky,et al. MHC class I expression in mice lacking the proteasome subunit LMP-7. , 1994, Science.
[33] H. Ploegh,et al. Generation, translocation, and presentation of MHC class I-restricted peptides. , 1995, Annual review of biochemistry.
[34] A. Goldberg,et al. Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[35] T. Elliott,et al. Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum , 1995, The Journal of experimental medicine.
[36] J. Yewdell,et al. Trimming of antigenic peptides in an early secretory compartment , 1994, The Journal of experimental medicine.
[37] A. Goldberg,et al. Lactacystin and clasto-Lactacystin β-Lactone Modify Multiple Proteasome β-Subunits and Inhibit Intracellular Protein Degradation and Major Histocompatibility Complex Class I Antigen Presentation* , 1997, The Journal of Biological Chemistry.
[38] Keiji Tanaka,et al. Double‐cleavage production of the CTL epitope by proteasomes and PA28: role of the flanking region , 1997, Genes to cells : devoted to molecular & cellular mechanisms.
[39] U. Koszinowski,et al. Sequence and structural organization of murine cytomegalovirus immediate-early gene 1 , 1987, Journal of virology.